Cannabis - Spark Newswire

2 minute read

IGC Q3 2023 Revenue Grows 133% YoY, What About Net Loss?

February 15, 8:40 AM

India Globalization Capital, Inc. (dba IGC, Inc.) (AMEX:IGC) released its third fiscal quarter 2023 financial results, revealing revenue of $332,000, a 133% increase compared to $142,000 in the Q3 2022. Q3 2023 Financial Highlights: Gross profit of $102,000 compared to $62,000 in Q3 2022.

IGC

2 minute read

Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program

By Lara Goldstein

February 14, 3:25 PM

Awakn Opens Fourth European Clinic, Norway Takes Center Stage

AWKNF

2 minute read

Cybin Reports Q3 Earnings, Says Psilocybin Tial Is Progressing As MDD Treatment

By Lara Goldstein

February 14, 2:58 PM

Cybin Inc. (NYSE: CYBN) has shared its unaudited financial results for the third quarter that ended Dec. 31, 2022. The company held total cash of $16.9 (CA$22.5) million as of Dec. 31, 2022, and $15 million as of Feb. 14, 2023.

CYBN

2 minute read

Health Canada Grants Exemption: Phase 2 Trial On Psilocybin For Genetic Disorder

By Lara Goldstein

February 14, 2:37 PM

Wellbeing Digital (OTC: KONEF) subsidiary KGK Sciences will advance with the first-ever Phase 2a clinical trial assessing repetitive, oral microdose psilocybin therapy for Fragile X Syndrome (FXS), a genetic disorder.

KONEF

2 minute read

TerrAscend Appoints Jeroen De Beijer As Chief People And Culture Officer

By Vuk Zdinjak

February 14, 11:09 AM

TerrAscend Corp. (OTCQX: TRSSF) (CSE:TER) announced the appointment of Jeroen De Beijer as chief people and culture officer. De Beijer brings more than 20 years of experience in global human resources and people management operations.

CSE:TER

2 minute read

Sean ‘Diddy’ Combs Expanding Business Portfolio With Rebranding Of Combs Enterprises To Combs Global

By Vuk Zdinjak

February 14, 10:52 AM

Sean "Diddy" Combs announced the rebranding of his parent company from Combs Enterprises to Combs Global.

CRLBF

2 minute read

cbdMD Q1 Net Sales Decline 35% YoY, What About Net Loss?

By Vuk Zdinjak

February 14, 9:48 AM

cbdMD, Inc. (AMEX:YCBD) released its first quarter of fiscal 2023 results, revealing net sales of $6.1 million, a decrease of 22% compared to net sales of $7.8 million in the Q4 2022, and a decrease of 35% compared to $9.3 million in the Q1 2022. Q1 2023 Financial Highlights

YCBD

1 minute read

‘Colorado Governor Promotes State’s First-Ever Marijuana Vending Machine’ -Marijuana Moment Report

By Benzinga Newsdesk

February 13, 2:16 PM

https://www.marijuanamoment.net/colorado-governor-promotes-states-first-ever-marijuana-vending-machine/

ACB

2 minute read

IM Cannabis Terminates The Panaxia Pharmacy Option

By Vuk Zdinjak

February 13, 12:19 PM

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) provided an update on its transaction with Panaxia Pharmaceutical Industries Israel Ltd. and Panaxia Logistics Ltd., part of the Panaxia Labs Israel, Ltd. group of companies, (collectively, "Panaxia").

CSE:IMCC